ARTICLE | Company News
Galapagos, PG adenovirus deal
October 22, 2001 7:00 AM UTC
Galapagos (Mechelen, Belgium) will use its PhenoSelect(r) adenovirus technology to make recombinant adenoviral vectors for Procter & Gamble Pharmaceuticals, a division of Procter & Gamble (PG). PG wil...